Live Breaking News & Updates on O Ipn Fr0010259150

Stay updated with breaking news from O ipn fr0010259150. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ipsen : delivers strong sales growth for the first nine months and improves its full-year guidance

Paris , 21 October 2021 - Ipsen , a global specialty-driven biopharmaceutical group, publishes its sales performance for the third quarter of 2021 and the year to date.

Sales. | June 16, 2023 ....

France General , United States , United Kingdom , Fanny Allaire , Ipsen Euronext , David Loew , Gwenan White , Drug Administration , Public Affairs , Global Communications , European Medicines Agency , Specialty Care , Chief Executive Officer , Accent Therapeutics , Nucleic Acids , Spherical Nucleic Acids , New Drug Application , Priority Review , European Medicines , Rare Disease , Consumer Healthcare , Sponsored Leveli American Depositary Receipt , Vice President , Ipsen Stock Exchange , Press Release , O Ipn Fr0010259150 ,